相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Effectiveness of Alternative Prostate-Specific Antigen-Based Prostate Cancer Screening Strategies Model Estimates of Potential Benefits and Harms
Roman Gulati et al.
ANNALS OF INTERNAL MEDICINE (2013)
Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up
Marcin Popiolek et al.
EUROPEAN UROLOGY (2013)
How to Decide Whether a Clinical Practice Guideline Is Trustworthy
David F. Ransohoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
Tuomas P. Kilpelainen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Early Detection of Prostate Cancer: AUA Guideline
H. Ballentine Carter et al.
JOURNAL OF UROLOGY (2013)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prostate cancer epidemiology in the United States
Otis W. Brawley
WORLD JOURNAL OF UROLOGY (2012)
Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001-2007
Jun Li et al.
PROSTATE CANCER (2012)
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
Hans Lilja et al.
CANCER (2011)
What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models
Roman Gulati et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Anna Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical practice guidelines to inform evidence-based clinical practice
J. Stuart Wolf et al.
WORLD JOURNAL OF UROLOGY (2011)
Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening
Caroline J. Savage et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
Jonas Hugosson et al.
LANCET ONCOLOGY (2010)
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
A Model of Prostate-Specific Antigen Screening Outcomes for Low- to High-Risk Men Information to Support Informed Choices
Kirsten Howard et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Staying at the cutting edge: a review and analysis of evidence reporting and grading; the recommendations of the American Urological Association
Martha Faraday et al.
BJU INTERNATIONAL (2009)
Prostate Specific Antigen Testing Among the Elderly-When To Stop?
Edward M. Schaeffer et al.
JOURNAL OF UROLOGY (2009)
Prostate Specific Antigen Best Practice Statement: 2009 Update
Kirsten L. Greene et al.
JOURNAL OF UROLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Individualized screening interval for prostate cancer based on prostate-specific antigen level - Results of a prospective, randomized, population-based study
G Aus et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Low levels of prostate-specific antigen predict long-term risk of prostate cancer: Results from the Baltimore Longitudinal Study of Aging
JY Fang et al.
UROLOGY (2001)
分享论文
